Intratympanic Steroids for Sudden Hearing Loss

Zhejiang University

Status: Unknown

Conditions: Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid

Treatments: Drug: Dexamethasone or Methylprednisolone

Study type: Interventional

Funder types: Other

Identifiers

NCT04129697

2019SHLRCT

Details and patient eligibility

About

For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

sudden hearing loss and initial treatment is not effective

Exclusion criteria

the patients refused intratympanic steroids treatment.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups

Dexamethasone

Active Comparator group

Treatment:

Drug: Dexamethasone or Methylprednisolone

Methylprednisolone

Active Comparator group

Treatment:

Drug: Dexamethasone or Methylprednisolone